Answers are grounded in this paper and cite their sources.
Obesity affects 42% of US adults and has a devastating impact on health. Although many patients initially lose weight with diet and exercise, long-term weight loss is difficult to achieve. Pharmacotherapy, as part of a comprehensive plan, can help patients lose weight and avoid regaining it. Choosing an antiobesity drug regimen should be an individualized, shared decision-making process that accounts for patient preferences, comorbidities, and out-of-pocket costs. We review antiobesity drugs and propose an individualized and comprehensive approach to obesity management.
No takes yet. Share an insight, caveat, or question.
Mauer et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: